Alloy Therapeutics, Inc. — Form D

Alloy Therapeutics, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-02. The offering totals $75.0M, of which $75.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Jay B RosanelliExecutive OfficerLEXINGTON, MA
Alaa HalawaRelated PersonAUSTIN, TX
Jason CammRelated PersonWALTHAM, MA
Anthony SunRelated PersonApex, NC
Jason ColomaDirectorAUSTIN, TX
Jason ColomaRelated PersonAUSTIN, TX
Alex KolicichRelated PersonWALTHAM, MA
Anthony B SunDirectorWALTHAM, MA
Alaa B HalawaDirectorWALTHAM, MA
Ulrik B NielsenDirectorWALTHAM, MA
Piotr B BobrowiczDirectorWALTHAM, MA
Piotr B BobrowiczExecutive OfficerWALTHAM, MA
Jason B CammDirectorWALTHAM, MA
Logan B SnyderDirectorWALTHAM, MA
Logan B SnyderExecutive OfficerWALTHAM, MA
Fabian B HansenDirectorWALTHAM, MA
Alex B KolicichDirectorWALTHAM, MA
Christian KanadyRelated PersonOklahoma City, OK
Logan SnyderRelated PersonWALTHAM, MA
Ulrik NielsenRelated PersonWALTHAM, MA
Errik B AndersonDirectorLEBANON, NH
Errik B AndersonExecutive OfficerLEBANON, NH
Errik B. AndersonRelated PersonCambridge, MA
Piotr BobrowiczRelated PersonWALTHAM, MA

Other filings by this issuer (2)

FiledFormOfferingSold
2026-04-15D$40.0M$30.0M
2022-10-03D$41.7M$41.7M

More